Daxor Corporation has introduced its ezBVA Lab diagnostic service for outpatient blood volume analysis at a healthcare facility in eastern Kansas. This service offers clinicians precise, 98% accurate blood volume measurements within 24 hours without the need for capital equipment or lab infrastructure. By providing objective data on blood, plasma, and red cell volume, the service helps optimize patient treatment, reduce hospital readmissions, and lower healthcare costs. This expansion strengthens Daxor's presence in the Midwest and supports value-based care improvements.
Schrödinger's stock fell 5.02% to $25.91 despite co-founding Tectora, a new biopharma venture with $55 million funding targeting immune and inflammatory treatments. The company, known for its molecular modeling software, holds a market value of about...
Johnson & Johnson reported third-quarter 2026 earnings per share of $2.59, surpassing analyst estimates of $2.52, with total revenue of $25.40 billion slightly above expectations. The company saw robust growth in its pharmaceutical segment, which off...
TSMC's preliminary Q3 2026 revenue reached approximately NT$1.49 trillion, about 50% higher year-over-year and above management guidance, driven by strong AI chip demand. The company holds a dominant 73% share of the global pure-play foundry market, ...
Inc. and SurveyMonkey have launched Growth Signals, a new initiative to regularly poll entrepreneurs and business leaders of fast-growing companies. This program aims to capture their priorities, challenges, and growth outlook to inform Inc.'s editor...
BNB Standard Corporation has launched a new corporate website featuring an expanded treasury dashboard that updates its Adjusted Net Asset Value and other key financial metrics intraday. This move aims to increase transparency and accountability in t...
